Comera Life Sciences Holdings, Inc. Capital Expenditures
Comera Life Sciences Holdings, Inc. reported Capital Expenditures of $94.01 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2023-11-09
- Comera Life Sciences Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Comera Life Sciences Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-06-30 was $5.65K.
- Comera Life Sciences Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-03-31 was $88.36K.
- Comera Life Sciences Holdings, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Comera Life Sciences Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $28.61K, a 79.86% decline from fiscal 2021.
- Comera Life Sciences Holdings, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $142.01K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.65K derived: sum of 2 quarters · filed 2023-11-09 | $94.01K 10-Q · filed 2023-11-09 | $94.01K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $5.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $94.01K 10-Q · filed 2023-08-10 | $94.01K derived: sum of 3 quarters · filed 2023-08-10 | $119.16K derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $88.36K 10-Q · filed 2023-05-12 | $88.36K derived: sum of 2 quarters · filed 2023-05-12 | $113.51K derived: sum of 3 quarters · filed 2023-11-09 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $25.15K derived: sum of 2 quarters · filed 2023-11-09 | $28.61K 10-K · filed 2023-03-17 | |
| 2022-09-30 | $25.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $28.61K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $3.45K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $130.55K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $142.01K 10-K · filed 2023-03-17 | ||
| 2021-09-30 | $11.46K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $12.37K 8-K · filed 2022-09-06 |